Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Volume: 366, Issue: 15, Pages: 1382 - 1392
Published: Apr 12, 2012
Abstract
Olaparib (AZD2281) is an oral poly(adenosine diphosphate [ADP]–ribose) polymerase inhibitor that has shown antitumor activity in patients with high-grade serous ovarian cancer with or without BRCA1 or BRCA2 germline...
Paper Details
Title
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Published Date
Apr 12, 2012
Volume
366
Issue
15
Pages
1382 - 1392
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History